Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)

被引：0

作者：

Shakespeare, William ^{[1
]}

Fantin, Valeria ^{[1
]}

Wang, Frank ^{[1
]}

Kohlmann, Anna ^{[1
]}

Liu, Shuangying ^{[1
]}

Huang, Wei-Sheng ^{[1
]}

Wang, Yihan ^{[1
]}

Zou, Dong ^{[1
]}

Thomas, Mathew ^{[1
]}

Li, Feng ^{[1
]}

Qi, Jiwei ^{[1
]}

Cai, Lisi ^{[1
]}

Dwight, Thimothy ^{[1
]}

Xu, Yongjin ^{[1
]}

Xu, Rongsong ^{[1
]}

Dodd, Rory ^{[1
]}

Xu, Qihong ^{[1
]}

Anjum, Rana ^{[1
]}

Zhang, Sen ^{[1
]}

Keats, Jeffrey ^{[1
]}

Xue, Ling ^{[1
]}

Wardwell, Scott ^{[1
]}

Ning, Yaoyu ^{[1
]}

Moran, Lauren ^{[1
]}

Mohemmad, Qurish ^{[1
]}

Zhu, Xiaotian ^{[1
]}

Narasimhan, Narayana ^{[1
]}

Rivera, Victor ^{[1
]}

Dalgarno, David ^{[1
]}

Clackson, Tim ^{[1
]}

机构：

[1] ARIAD Pharmaceut, Cambridge, MA USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3738

引用

页数：2

共 50 条

[1] Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors
Lovly, C. M.
de Stanchina, E.
Chen, H.
Liang, C.
Pao, W.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Lewis, Richard T.
Bode, Christiane M.
Choquette, Deborah M.
Potashman, Michele
Romero, Karina
Stellwagen, John C.
Teffera, Yohannes
Moore, Earl
Whittington, Douglas A.
Chen, Hao
Epstein, Linda F.
Emkey, Renee
Andrews, Paul S.
Yu, Violeta L.
Saffran, Douglas C.
Xu, Man
Drew, Allison
Merkel, Patricia
Szilvassy, Steven
Brake, Rachael L.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (14) : 6523 - 6540
[3] Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery
Wang, Wen-Chieh
Shiao, Hui-Yi
Lee, Chieh-Chien
Fung, Ka-Shu
Hsieh, Hsing-Pang
[J]. MEDCHEMCOMM, 2014, 5 (09) : 1266 - 1279
[4] Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1
Degnan, Andrew P.
Kumi, Godwin K.
Allard, Christopher W.
Araujo, Erika, V
Johnson, Walter L.
Zimmermann, Kurt
Pearce, Bradley C.
Sheriff, Steven
Futran, Alan
Li, Xin
Locke, Gregory A.
You, Dan
Morrison, John
Parrish, Karen E.
Stromko, Caitlyn
Murtaza, Anwar
Liu, Jinqi
Johnson, Benjamin M.
Vite, Gregory D.
Wittman, Mark D.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (03): : 443 - 450
[5] Discovery of AP26113, a potent, orally active inhibitor of anaplastic lymphoma kinase and clinically relevant mutants
Huang, Wei-Sheng
Li, Feng
Cai, Lisi
Xu, Yongjin
Zhang, Sen
Wardwell, Scott D.
Ning, Yaoyu
Kohlmann, Anna
Zhou, Tianjun
Ye, Emily Y.
Zhu, Xiaotian
Narasimhan, Narayana I.
Clackson, Tim
Rivera, Victor M.
Dalgarno, David
Shakespeare, William C.
[J]. CANCER RESEARCH, 2015, 75
[6] Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)
Kinoshita, Kazutomo
Asoh, Kohsuke
Furuichi, Noriyuki
Ito, Toshiya
Kawada, Hatsuo
Hara, Sousuke
Ohwada, Jun
Miyagi, Takuho
Kobayashi, Takamitsu
Takanashi, Kenji
Tsukaguchi, Toshiyuki
Sakamoto, Hiroshi
Tsukuda, Takuo
Oikawa, Nobuhiro
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1271 - 1280
[7] Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK)
Kong, Xiaotian
Pan, Peichen
Sun, Huiyong
Xia, Hongguang
Wang, Xuwen
Li, Youyong
Hou, Tingjun
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (24) : 10927 - 10954
[8] Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2
Nguyen, Minh H.
Atasoylu, Onur
Wu, Liangxing
Kapilashrami, Kanishk
Pusey, Michelle
Gallagher, Karen
Lai, Cheng-Tsung
Zhao, Peng
Barbosa, Joseph
Liu, Kai
He, Chunhong
Zhang, Colin
Styduhar, Evan D.
Witten, Michael R.
Chen, Yaoyu
Lin, Luping
Yang, Yan-ou
Covington, Maryanne
Diamond, Sharon
Yeleswaram, Swamy
Yao, Wenqing
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1159 - 1164
[9] Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase
Gingrich, Diane E.
Lisko, Joseph G.
Curry, Matthew A.
Cheng, Mangeng
Quail, Matthew
Lu, Lihui
Wan, Weihua
Albom, Mark S.
Angeles, Thelma S.
Aimone, Lisa D.
Haltiwanger, R. Curtis
Wells-Knecht, Kevin
Ott, Gregory R.
Ghose, Arup K.
Ator, Mark A.
Ruggeri, Bruce
Dorsey, Bruce D.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4580 - 4593
[10] Discovery of pyrazolimidazopyridine compounds as potent in vitro and in vivo anaplastic lymphoma kinase inhibitors
Saeh, Jamal C.
Yang, Bin
Pen, Bo
Kamhi, Victor
Harrison, Rane
Rivard, Caroline
Wu, Allan
Drew, Lisa
Russell, Daniel J.
[J]. CANCER RESEARCH, 2012, 72

← 1 2 3 4 5 →